// App-Quantinova.ai

: Mepolizumab Improves Health Related Quality of Life for Patients with Chronic Rhinosinusitis with Nasal Polyps: Data from the SYNAPSE study

Researchers

Presenter

  • Stella Lee

Principal Investigators

  • Maggie Tabberer

  • Andrew Trigg

  • Joseph Han

  • Wytske Fokkens

  • Robert Naclerio

  • Philippe Gevaert

  • Ana Sousa

  • Peter Howarth

  • Bhabita Mayer

  • Steven Yancey

  • Robert Chan

Medical Centers

  • University of Pittsburgh, School of Medicine, Pittsburgh, PA

  • GSK, Stockley Park, Uxbridge, Middlesex, UK

  • Adelphi Values Ltd, Manchester, UK

  • Eastern Virginia Medical School, Norfolk, VA

  • Amsterdam University Medical Centres, Location AMC Amsterdam, Amsterdam, The Netherlands

  • Surgery, University Chicago, Chicago, Illinois, United States

  • Ghent University Hospital, Ghent, Belgium

  • GSK, Brentford, London, UK

  • GSK, Research Triangle Park, NC, USA

  • GSK, Stevenage

Locations

  • United States

  • United Kingdom

  • Netherlands

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Mepolizumab

Outcome

  • N/A


Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A